Cargando…
The Potential of Drug Delivery Nanosystems for Sepsis Treatment
Sepsis is a major immune response disorder caused by infection, with very high incidence and mortality rates. In the clinic, sepsis and its complications are mainly controlled and treated with antibiotics, anti-inflammatory, and antioxidant drugs. However, these treatments have some shortcomings, su...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702780/ https://www.ncbi.nlm.nih.gov/pubmed/34984019 http://dx.doi.org/10.2147/JIR.S339113 |
_version_ | 1784621318907363328 |
---|---|
author | Shi, Yi Zhu, Meng-Lu Wu, Qian Huang, Yi Xu, Xiao-Ling Chen, Wei |
author_facet | Shi, Yi Zhu, Meng-Lu Wu, Qian Huang, Yi Xu, Xiao-Ling Chen, Wei |
author_sort | Shi, Yi |
collection | PubMed |
description | Sepsis is a major immune response disorder caused by infection, with very high incidence and mortality rates. In the clinic, sepsis and its complications are mainly controlled and treated with antibiotics, anti-inflammatory, and antioxidant drugs. However, these treatments have some shortcomings, such as rapid metabolism and severe side effects. The emergence of drug delivery nanosystems can significantly improve tissue permeability, prolong drugs’ circulation time, and reduce side effects. In this paper, we reviewed recent drug delivery nanosystems designed for sepsis treatment based on their mechanisms (anti-bacterial, anti-inflammatory, and antioxidant). Although great progress has been made recently, clinical practice transformation is still very difficult. Therefore, we also discussed key obstacles, including tissue distribution, overcoming bacterial resistance, and single treatment modes. Finally, a rigorous optimization of drug delivery nanosystems is expected to present great potential for sepsis therapy. |
format | Online Article Text |
id | pubmed-8702780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-87027802022-01-03 The Potential of Drug Delivery Nanosystems for Sepsis Treatment Shi, Yi Zhu, Meng-Lu Wu, Qian Huang, Yi Xu, Xiao-Ling Chen, Wei J Inflamm Res Review Sepsis is a major immune response disorder caused by infection, with very high incidence and mortality rates. In the clinic, sepsis and its complications are mainly controlled and treated with antibiotics, anti-inflammatory, and antioxidant drugs. However, these treatments have some shortcomings, such as rapid metabolism and severe side effects. The emergence of drug delivery nanosystems can significantly improve tissue permeability, prolong drugs’ circulation time, and reduce side effects. In this paper, we reviewed recent drug delivery nanosystems designed for sepsis treatment based on their mechanisms (anti-bacterial, anti-inflammatory, and antioxidant). Although great progress has been made recently, clinical practice transformation is still very difficult. Therefore, we also discussed key obstacles, including tissue distribution, overcoming bacterial resistance, and single treatment modes. Finally, a rigorous optimization of drug delivery nanosystems is expected to present great potential for sepsis therapy. Dove 2021-12-19 /pmc/articles/PMC8702780/ /pubmed/34984019 http://dx.doi.org/10.2147/JIR.S339113 Text en © 2021 Shi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Shi, Yi Zhu, Meng-Lu Wu, Qian Huang, Yi Xu, Xiao-Ling Chen, Wei The Potential of Drug Delivery Nanosystems for Sepsis Treatment |
title | The Potential of Drug Delivery Nanosystems for Sepsis Treatment |
title_full | The Potential of Drug Delivery Nanosystems for Sepsis Treatment |
title_fullStr | The Potential of Drug Delivery Nanosystems for Sepsis Treatment |
title_full_unstemmed | The Potential of Drug Delivery Nanosystems for Sepsis Treatment |
title_short | The Potential of Drug Delivery Nanosystems for Sepsis Treatment |
title_sort | potential of drug delivery nanosystems for sepsis treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702780/ https://www.ncbi.nlm.nih.gov/pubmed/34984019 http://dx.doi.org/10.2147/JIR.S339113 |
work_keys_str_mv | AT shiyi thepotentialofdrugdeliverynanosystemsforsepsistreatment AT zhumenglu thepotentialofdrugdeliverynanosystemsforsepsistreatment AT wuqian thepotentialofdrugdeliverynanosystemsforsepsistreatment AT huangyi thepotentialofdrugdeliverynanosystemsforsepsistreatment AT xuxiaoling thepotentialofdrugdeliverynanosystemsforsepsistreatment AT chenwei thepotentialofdrugdeliverynanosystemsforsepsistreatment AT shiyi potentialofdrugdeliverynanosystemsforsepsistreatment AT zhumenglu potentialofdrugdeliverynanosystemsforsepsistreatment AT wuqian potentialofdrugdeliverynanosystemsforsepsistreatment AT huangyi potentialofdrugdeliverynanosystemsforsepsistreatment AT xuxiaoling potentialofdrugdeliverynanosystemsforsepsistreatment AT chenwei potentialofdrugdeliverynanosystemsforsepsistreatment |